Pharmaceutical Manufacturers Guide to OIG Compliance

Verisys can assist pharmaceutical manufacturers in maintaining compliance with OIG guidelines and other regulatory requirements through a multifaceted approach, leveraging its extensive suite of data solutions and compliance services.

Here’s how Verisys can support pharmaceutical manufacturers in this critical area:

Comprehensive Background Screening and Credentialing:

Verisys’ FACIS (Fraud and Abuse Control Information System) is a key tool for screening and continuous monitoring of healthcare providers. It can verify licensure, check for disciplinary actions, and ensure that individuals and entities are not excluded or sanctioned, which is essential for maintaining compliance with OIG guidelines and preventing fraud and abuse​​​​​​.

OIG Compliance via FACIS:

Specifically, Verisys, through FACIS, provides solutions to ensure compliance with OIG guidelines by offering extensive screening and monitoring services. This includes covering both federal and state-level exclusions and sanctions, which is vital for pharmaceutical manufacturers to ensure that they do not engage with any sanctioned or excluded individuals or entities, thereby maintaining compliance and avoiding potential fines and penalties​​​​.

License Verification and Ongoing Monitoring:

Verisys offers license verification services, including the status, expiration dates, and any disciplinary actions associated with healthcare licenses. Continuous monitoring of licenses and certifications is crucial to ensure that all practitioners and entities engaged by pharmaceutical manufacturers remain in good standing, which aligns with the OIG’s emphasis on the integrity of relationships with healthcare providers​​​​.

Provider Directory Management:

By managing up-to-date provider directories, Verisys helps pharmaceutical manufacturers ensure that they are engaging with compliant and properly credentialed healthcare providers. This is particularly important for manufacturers in managing their relationships with physicians and other healthcare professionals who may influence the prescribing of drugs​​.

Data Verification Beyond Healthcare Licenses:

Verisys’ verification services extend to other critical datasets, such as the Office of Foreign Assets Control (OFAC), Drug Enforcement Administration (DEA), and Abuse Registries, among others. This comprehensive approach to data verification helps pharmaceutical manufacturers to manage their risk and ensure compliance across multiple regulatory requirements​​.

Alignment with Industry Standards and Regulations:

Verisys ensures that its services and solutions are aligned with regulations set by state, federal, and standard-setting organizations, such as the Joint Commission, URAC (Utilization Review Accreditation Commission), and NCQA (National Committee for Quality Assurance). This alignment is crucial for pharmaceutical manufacturers to ensure that they meet or exceed industry compliance standards​​.

By leveraging Verisys’ comprehensive compliance solutions, pharmaceutical manufacturers can effectively navigate the complex regulatory landscape, maintain ethical practices, and ensure compliance with OIG guidelines and other critical regulatory requirements. This holistic approach to compliance not only helps in mitigating risk but also in maintaining the integrity and reputation of pharmaceutical manufacturers in the highly regulated healthcare industry.

Learn more about all Verisys can offer your organization by speaking with a member of our team here.